Radiation Based Crosslink
The computed 12-month bankruptcy probability of Radiation Based Crosslink is 1.8% (moderate). The 2025 annual accounts show equity of €31k and a net result of €-137k. Equity is shrinking by ~35.6% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2026. Its solvency ranks better than 12% of 7779 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €31k |
| Net result | €-137k |
| Staff (FTE) | 5.5 |
| Better than sector | 12% |
Fragile profile, watch profitability in particular.
All 5 axes are computed from data Checked has read.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 2.1% | 44.6% | |
| Net result | €-137k | €31k | |
| Equity | €31k | €395k | |
| Gross operating margin | €370k | €210k | |
| Staff costs | €411k | €189k |
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Deposit | abbreviated schema | abbreviated schema | abbreviated schema |
| Revenue | - | - | - |
| EBITDA | €-47k | €270k | €140k |
| Net profit | €-137k | €179k | €83k |
| Cash flow | €-60k | €214k | €115k |
| Staff costs | €411k | €234k | €167k |
| Income taxes | €361 | €57k | €26k |
| Dividends | €0 | €119k | - |
| Total assets | €1.49M | €1.55M | €981k |
| Equity | €31k | €168k | €108k |
| Debt | €1.46M | €1.38M | €872k |
| of which ≤ 1y | €1.19M | €1.16M | €833k |
| of which > 1y | €267k | €216k | €39k |
| Working capital | €-127k | €139k | €-8k |
| Employees (FTE) | 5.5 | 3.0 | 1.8 |
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Current ratio | 0.89 | 1.12 | 0.99 |
| Quick ratio | 0.35 | 0.59 | 0.48 |
| Working capital ratio | -8.6% | 9.0% | -0.9% |
| Solvency | 2.1% | 10.9% | 11.1% |
| Debt / equity | 46.73 | 8.20 | 8.05 |
| Long-term debt ratio | 8.54 | 1.28 | 0.36 |
| Interest coverage | -2.19 | 59.89 | 65.16 |
| Gross margin | - | - | - |
| Net margin | - | - | - |
| ROA | -9.2% | 11.6% | 8.5% |
| ROE | -438.1% | 106.4% | 76.9% |
| EBITDA margin | - | - | - |
| Days sales outstanding | - | - | - |
| Days payable outstanding | - | - | - |
| Inventory turnover | - | - | - |
| Days inventory (DSI) | - | - | - |
Full annual accounts (25 line items)
| Line item | Code | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Balance sheet, Assets | ||||
| TOTAL ASSETS | 20/58 | €1.49M | €1.55M | €981k |
| Fixed assets | 21/28 | €426k | €245k | €156k |
| Intangible fixed assets | 21 | €16k | €13k | €6k |
| Tangible fixed assets | 22/27 | €410k | €232k | €146k |
| Financial fixed assets | 28 | €372 | €0 | €5k |
| Current assets | 29/58 | €1.06M | €1.30M | €825k |
| Stocks & contracts in progress | 3 | €651k | €616k | €424k |
| Amounts receivable within one year | 40/41 | €322k | €491k | €360k |
| Cash & bank | 54/58 | €87k | €182k | €37k |
| Balance sheet, Equity & liabilities | ||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.49M | €1.55M | €981k |
| Equity | 10/15 | €31k | €168k | €108k |
| Contributions / capital | 10/11 | €25k | €25k | €25k |
| Accumulated profits (losses) | 14 | €6k | €143k | €83k |
| Amounts payable | 17/49 | €1.46M | €1.38M | €872k |
| Amounts payable after one year | 17 | €267k | €216k | €39k |
| Amounts payable within one year | 42/48 | €1.19M | €1.16M | €833k |
| Trade debts payable within one year | 44 | €226k | €238k | €166k |
| Income statement | ||||
| Gross operating margin | 9900 | €370k | €541k | €309k |
| Operating result | 9901 | €-123k | €234k | €109k |
| Financial income | 75 | €9k | €6k | €2k |
| Financial charges | 65 | €21k | €5k | €2k |
| Result before taxes | 9903 | €-136k | €236k | €109k |
| Income taxes | 67/77 | €361 | €57k | €26k |
| Net result for the period | 9904 | €-137k | €179k | €83k |
| Result to be appropriated | 9905 | €-137k | €179k | €83k |
-
JDQ CONSULTANCYPrivate limited companyDirector· perm. rep.: Jordy DeclercqState Gazette act 24107811 (17-07-2024)Current14-06-2024 → present
Former directors (1)
-
VOF GEROCELegal entityDirector· perm. rep.: Ronny VANDE WALLEState Gazette act 25150180 (26-11-2025)Former- → 17-11-2025
| NACE primary | Wholesale of industrial chemicals(46851) |
| Legal form | Private limited company(610) |
| Incorporation | 27-09-2022 |
| Status | Active |
| Postal code | 9770 |
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 45017C0067/00H000 | Flanders | 2,786 m² | 1 · 142 m² | 5.5 m · 1 fl. |
We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
26-11-2025 Ronny VANDE WALLE resigns as director
- Ronny VANDE WALLE, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Ronny VANDE WALLE",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "VOF GEROCE",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-11-17",
"evidence_quote": "VOF GEROCE, vertegenwoordigd door de heer Ronny VANDE WALLE brengt de aanwezige bestuursleden en aandeelhouders op de hoogte van zijn vrijwillig ontslag als bestuurder van BV ! Radiation Based Crosslink, en dit met onmiddellijke ingang op 17 november 2025."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0791.464.867",
"name_full": "RADIATION BASED CROSSLINK, AFGEKORT : RBC",
"legal_form": "BV"
}
}10-02-2025 VOF GEROCE appointed as director
- VOF GEROCE, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "VOF GEROCE",
"address": null,
"birth_date": null
},
"effective_date": "2025-01-13",
"evidence_quote": "De algemene vergadering beslist tot de benoeming van VOF GEROCE, met zetel te 9030 Gent Hogekouterstraat 120, als niet-statutaire bestuurder, en dit met ingang op 13/01/2025."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0791.464.867",
"name_full": "RADIATION BASED CROSSLINK, AFGEKORT : RBC",
"legal_form": "BV"
}
}26-09-2024 Registered office moved from Deinze to Kruisem
- E 3 laan 43, 9800 Deinze → Karreweg 141, 9770 Kruisem
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Kruisem",
"region": null,
"street": "Karreweg",
"country": "BE",
"postcode": "9770",
"box_number": "A",
"street_number": "141"
},
"old_address": {
"city": "Deinze",
"region": null,
"street": "E 3 laan",
"country": "BE",
"postcode": "9800",
"box_number": null,
"street_number": "43"
},
"effective_date": "2024-10-01",
"evidence_quote": "Het bestuur beslist dat de zetel van de vennootschap zal worden verplaatst van E 3 laan 43, 9800 Deinze naar Karreweg 141, Bus A, 9770 Kruisem, en dit vanaf 01/10/2024."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0791.464.867",
"name_full": "RADIATION BASED CROSSLINK, AFGEKORT : RBC",
"legal_form": "BV"
}
}17-07-2024 Jordy Declercq appointed as director
- Jordy Declercq, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jordy Declercq",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "1008794654",
"name": "BV JDQ CONSULTANCY",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-06-14",
"evidence_quote": "De algemene vergadering beslist tot de benoeming van BV JDQ CONSULTANCY, met zetel te 8581 Avelgem Oudenaardsesteenweg 585, gekend onder het ondernemingsnummer 1008.794.654, vast vertegenwoordigd door dhr. Jordy Declercq als niet-statutaire bestuurder, en dit met ingang op 14/06/2024."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0791.464.867",
"name_full": "RADIATION BASED CROSSLINK, AFGEKORT : RBC",
"legal_form": "BV"
}
}29-09-2022 Incorporation of a new BV
Technical details
{
"kind": "oprichting",
"seat": "9800 Deinze, E 3 laan 43",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": "0425.861.672",
"name": "DRUKKERIJ VOET"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Aandelen",
"partner_role": null,
"holder_org_kbo": "0425.861.672",
"holder_org_name": "DRUKKERIJ VOET",
"contribution_type": "cash",
"amount_paid_in_eur": 25000,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 250,
"amount_subscribed_eur": 25000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 25000,
"subject_company": {
"kbo": "0791.464.867",
"name_full": "Radiation Based Crosslink",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2022-09-26",
"post_incorporation_mandates": []
}| Legal nameNL | Radiation Based Crosslink |
| AbbreviationNL | RBC |